On top of it, if you look at the last three-four quarters, there is a weak job hiring when it comes to IT sector and weak salary growth. And adding to that, if you look at last three-four quarters, banks and NBFCs have been cautious when it comes to retail lending.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,